Insider Stock Trading History of Spangler Jonathan


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Spangler Jonathan since year 2005. The trader's CIK number is 1312160. At the time of this reporting, Spangler Jonathan is the Chief Patent Counsel of Nuvasive Inc . (stock ticker symbol NUVA). See this page for all insider trading activities at Nuvasive Inc .


Stock purchases, sales, and option exercises reported by insider Spangler Jonathan since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2006-12-28 NUVA Nuvasive Inc Option Ex 8,500 .63 5,355
2006-12-28 NUVA Nuvasive Inc Sale 8,500 23.65 201,059
2006-11-28 NUVA Nuvasive Inc Sale 1,000 21.84 21,837
2006-11-28 NUVA Nuvasive Inc Option Ex 1,000 .63 630
2006-10-26 NUVA Nuvasive Inc Option Ex 1,000 .63 630
2006-10-26 NUVA Nuvasive Inc Sale 1,000 24.07 24,074
2006-09-28 NUVA Nuvasive Inc Sale 1,000 20.67 20,670
2006-09-28 NUVA Nuvasive Inc Option Ex 1,000 .63 630
2006-08-25 NUVA Nuvasive Inc Option Ex 1,000 .63 630
2006-08-25 NUVA Nuvasive Inc Sale 1,000 18.74 18,735
2006-07-28 NUVA Nuvasive Inc Option Ex 6,000 .63 3,780
2006-07-28 NUVA Nuvasive Inc Sale 6,000 17.20 103,212
2006-06-27 NUVA Nuvasive Inc Option Ex 15,000 .63 9,450
2006-06-27 NUVA Nuvasive Inc Sale 15,000 17.46 261,840
2006-02-28 NUVA Nuvasive Inc Sale 1,500 18.58 27,867
2006-01-30 NUVA Nuvasive Inc Sale 1,500 17.96 26,932
2005-12-28 NUVA Nuvasive Inc Sale 1,500 18.14 27,214
2005-11-28 NUVA Nuvasive Inc Sale 1,500 17.12 25,672
2005-10-27 NUVA Nuvasive Inc Sale 1,500 18.67 28,006
2005-09-28 NUVA Nuvasive Inc Sale 1,500 18.03 27,045
2005-08-25 NUVA Nuvasive Inc Sale 1,500 19.22 28,830
2005-07-28 NUVA Nuvasive Inc Sale 1,500 19.26 28,890
2005-06-27 NUVA Nuvasive Inc Sale 1,500 17.06 25,589
2005-05-26 NUVA Nuvasive Inc Sale 1,500 15.05 22,575
2005-04-27 NUVA Nuvasive Inc Sale 1,500 13.90 20,850
2005-03-28 NUVA Nuvasive Inc Sale 7,500 12.45 93,382

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Spangler Jonathan (Chief Patent Counsel of Nuvasive Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.